Cineverse Reports First Quarter Fiscal Year 2026 Results
14 augusti, 22:01
14 augusti, 22:01
Cineverse Reports First Quarter Fiscal Year 2026 Results
PR Newswire
LOS ANGELES, Aug. 14, 2025
Total Revenue of $11.1 Million , a $2.0 million or 22% Increase over Prior Year Quarter
Direct Operating Margin of 57%, a 6% Improvement over Prior Year Quarter
LOS ANGELES , Aug. 14, 2025 /PRNewswire/ -- Cineverse Corp. ("Cineverse" or the "Company") (NASDAQ: CNVS), a global streaming technology and entertainment company, today announced its financial results for its first quarter ended June 30, 2025 ("Q1 FY 2026"):
The Company's Total Revenue and Direct Operating Margin improved significantly over the prior year quarter while Net Loss and Adjusted EBITDA decreased slightly due to increased SG&A costs directly attributable to the investments required to support our increased theatrical slate and build out of an enhanced business development, product and sales team for our Technology group.
Following the unprecedented success of Terrifier 3 , the most successful unrated film release of all time, we continue to build a slate of additional wide release films that we believe can provide a strong and ongoing source of profits for the Company. The Toxic Avenger Unrated , produced by major studio Legendary Films (Dune, Godzilla x Kong, etc.), hits theatres on August 29 , 2025. After that, Silent Night, Deadly Night , a re-interpretation of the classic controversial horror film, is scheduled for release on December 12, 2025 . Next will be Return to Silent Hill , the latest film installment of the enormously successful video game franchise, on January 23 , 2026. Additionally, in summer 2026, we will release Air Bud Returns , the latest installment of the beloved family film franchise. We will also be releasing Wolf Creek : Legacy , the third installment of the classic Australian Outback horror/thriller film, in 2027. Based on the results of Terrifier 2 and Terrifier 3 , other major studios also continue to utilize our new media ecosystem to market their releases, emphasizing the impact our unique and innovative marketing approach has had on the industry.
The Company continues to be in a strong financial position as of June 30, 2025 with almost $10.9 million in cash-on-hand and availability on our current $12.5 million line of credit facility with East West Bank .
Q1 FY 2026 Highlights (all comparisons are to the prior year fiscal quarter ended June 30, 2024 , or Q1 FY 2025):
Total quarterly revenue was $11.1 million versus $9.1 million in the prior-year period, a 22% increase, driven by gains in streaming and digital distribution, as well as theatrical and physical sales.
SG&A expenses increased by $2.4 million , or 36%, to $9.0 million , reflecting increased compensation, marketing and legal costs as a result of ramping up for an increased theatrical slate for the remainder of the year. The Company's SG&A costs are typically higher in the first quarter of the fiscal year due to increased costs associated with year-end audit, tax and Sarbanes-Oxley compliance.
Net loss attributable to common stockholders was $3.6 million , or $(0.21) per basic and diluted share, compared to a net loss of $3.2 million , or $(0.20) per share, in the prior-year quarter. Adjusted EBITDA was $(2.1) million , compared to $(1.4) million last year.
Financial Condition Overview:
Operational Developments During the Quarter:
Operational Developments Subsequent to Quarter-End:
Management Commentary:
Chris McGurk , Cineverse Chairman and CEO , stated: "We had another strong quarter from a Revenue standpoint, with significant growth across all of our lines of business. Our total Operating Margin also increased significantly. Investments in SG&A and marketing to support our expanding theatrical business and our Technology Group impacted our Adjusted EBITDA and Net Income. However, we expect to begin to see returns from those investments beginning in our fiscal second quarter."
"The Toxic Avenger Unrated hits theaters on August 29 , and received a strong response at Comic-Con last month. Similar to Terrifier 3 , our total investment in this film, including release marketing, is less than $5 million . However, since we bought out all domestic rights in all media for the film in perpetuity under a unique deal structure, the risk/reward profile for this film is much more favorable for Cineverse."
"We also added another high potential film to our slate: We will be releasing Air Bud Returns , the latest theatrical installment of the beloved film and TV family franchise that was previously distributed for more than the last two decades by the Walt Disney Company, next summer. Our announcement of Air Bud Returns garnered huge interest across all media including features on Good Morning America and The Today Show."
"Finally, we recently announced a 50/50 joint venture for MicroCo, a new studio and platform for Microseries, a market projected to reach $10 billion by 2027. Our partner for MicroCo is Lloyd Braun's Banyan Ventures. Lloyd is the former Chairman of ABC Entertainment and WME. Joining the venture as CEO will be Jana Winograde , former Showtime President, and CCO Susan Rovner, former Chairman of NBC/Universal Television and Streaming. We believe Cineverse's unique set of streaming, content, technology and AI capabilities will provide a tremendous foundation of assets for this elite leadership team to rapidly build an industry-leading business in this high growth sector."
Erick Opeka , Cineverse President and Chief Strategy Officer , stated: "Cineverse is proving that when you combine owned ad tech, proprietary media networks, and a disciplined theatrical acquisition strategy, you can achieve studio-level awareness with a fraction of the spend. Ahead of its release, awareness tracking for The Toxic Avenger Unrated is already above its opening weekend peers across multiple third-party measurement sources while our marketing investment remains less than ten percent of comparable studio campaigns. This is the advantage of controlling the pipes and the platform."
"The same machine driving that theatrical awareness is also fueling growth across our streaming business, with total minutes streamed up 38% year-over-year to more than 4.0 billion and FAST viewing up 20%. Screambox viewership has climbed 26% since the release of Terrifier 3 , showing how our approach can both launch films and deepen engagement across our platforms. The addition of industry leader Michele Edelman to head sales and marketing for Matchpoint strengthens our ability to extend these results to new enterprise clients."
"Our recently announced MicroCo joint venture is another example of how we intend to lead emerging formats rather than follow them. Our goal is to build the infrastructure layer for the entire microdrama space, unifying content, creators, fandom, and monetization under one platform. Powered by Cineverse's proprietary technology and AI capabilities, MicroCo will support all forms of content generation, from premium live-action to AI-assisted production, hybrid workflows, animation, and creator-led formats. Backed by some of the most accomplished executives in the history of television and combined with our distribution, marketing, and data-driven audience development tools, we believe MicroCo can define the future of short-form storytelling and become the standard the category grows on."
Conference Call
Cineverse will host a conference call at 4:30 p.m. EST / 1:30 p.m. PST ( Thursday, August 14, 2025 ), during which management will discuss the results of its fiscal first quarter ended June 30, 2025 .
Call details are as follows:
About Cineverse
Cineverse (Nasdaq: CNVS) is a next-generation entertainment studio that empowers creators and entertains fans with a wide breadth of content through the power of technology. It has developed a new blueprint for delivering entertainment experiences to passionate audiences and results for its partners with unprecedented efficiency, and distributes more than 71,000 premium films, series, and podcasts. Cineverse connects fans with bold, authentic, independent stories. Properties include the highest-grossing unrated film in U.S. history ; dozens of streaming fandom channels; a premier podcast network; top horror destination Bloody Disgusting; and more. Powering visionary storytelling with cutting-edge innovation, Cineverse's proprietary streaming tools and AI technology drive revenue and reach to redefine the next era of entertainment. For more information, visit home.cineverse.com .
Safe Harbor Statement
Investors and readers are cautioned that certain statements contained in this document, as well as some statements in periodic press releases and some oral statements of Cineverse officials during presentations about Cineverse, along with Cineverse's filings with the Securities and Exchange Commission, including Cineverse's registration statements, quarterly reports on Form 10-Q and annual report on Form 10-K, are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act''). Forward-looking statements include statements that are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "expects," "anticipates,'' "intends,'' "plans,'' "could," "might," "believes,'' "seeks," "estimates'' or similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings, or growth rates), ongoing business strategies or prospects, and possible future actions, which may be provided by Cineverse's management, are also forward-looking statements as defined by the Act. Forward-looking statements are based on current expectations and projections about future events and are subject to various risks, uncertainties, and assumptions about Cineverse, its technology, economic and market factors, and the industries in which Cineverse does business, among other things. These statements are not guarantees of future performance, and Cineverse undertakes no specific obligation or intention to update these statements after the date of this release.
For additional information, please contact:
Julie Milstead
424-281-5411
investorrelations@cineverse.com
CINEVERSE CORP. | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(in thousands) | ||||||||
As of | ||||||||
June 30, | March 31, | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | 1,985 | $ | 13,941 | ||||
Accounts receivable, net | 16,073 | 15,752 | ||||||
Content advances | 5,168 | 6,736 | ||||||
Other current assets | 1,637 | 1,652 | ||||||
Total Current Assets | 24,863 | 38,081 | ||||||
Property and equipment, net | 2,968 | 2,876 | ||||||
Intangible assets, net | 18,449 | 18,168 | ||||||
Goodwill | 6,799 | 6,799 | ||||||
Content advances, net of current portion | 5,853 | 4,053 | ||||||
Other long-term assets | 2,602 | 2,539 | ||||||
Total Assets | $ | 61,534 | $ | 72,516 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities | ||||||||
Accounts payable and accrued expenses | $ | 20,757 | $ | 31,109 | ||||
Line of credit | 3,628 | - | ||||||
Current portion of earnout and deferred consideration on purchase of business | 464 | 2,956 | ||||||
Current portion of operating lease liabilities | 191 | 187 | ||||||
Current portion of deferred revenue | 99 | 183 | ||||||
Total Current Liabilities | 25,139 | 34,435 | ||||||
Operating lease liabilities, net of current portion | 226 | 275 | ||||||
Other long-term liabilities | 15 | 14 | ||||||
Total Liabilities | 25,380 | 34,724 | ||||||
Stockholders' Equity | ||||||||
Preferred stock | 3,559 | 3,559 | ||||||
Common Stock | 195 | 194 | ||||||
Additional paid-in capital | 551,320 | 548,405 | ||||||
Treasury stock, at cost | (13,158) | (12,193) | ||||||
Accumulated deficit | (504,557) | (500,908) | ||||||
Accumulated other comprehensive loss | (289) | (305) | ||||||
Total stockholders' equity of Cineverse Corp. | 37,070 | 38,752 | ||||||
Deficit attributable to noncontrolling interest | (916) | (960) | ||||||
Total equity | 36,154 | 37,792 | ||||||
Total Liabilities and Equity | $ | 61,534 | $ | 72,516 |
CINEVERSE CORP. | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||
(In thousands, except for per share data) | ||||||||
(Unaudited) | ||||||||
Three Months Ended | ||||||||
2025 | 2024 | |||||||
Revenues | $ | 11,119 | $ | 9,127 | ||||
Operating expenses | ||||||||
Direct operating | 4,807 | 4,479 | ||||||
Selling, general and administrative | 8,952 | 6,563 | ||||||
Depreciation and amortization | 1,062 | 863 | ||||||
Total operating expenses | 14,821 | 11,905 | ||||||
Operating loss | (3,702) | (2,778) | ||||||
Interest income (expense) | 278 | (431) | ||||||
Other (expense) income, net | (78) | 166 | ||||||
Net loss before income taxes | (3,502) | (3,043) | ||||||
Income tax expense | (14) | (7) | ||||||
Net loss | (3,516) | (3,050) | ||||||
Net income attributable to noncontrolling interest | (44) | (23) | ||||||
Net loss attributable to controlling interests | (3,560) | (3,073) | ||||||
Preferred stock dividends | (89) | (89) | ||||||
Net loss attributable to common stock holders | $ | (3,649) | $ | (3,162) | ||||
Net loss per share attributable to common stockholders: | ||||||||
Basic | $ | (0.21) | $ | (0.20) | ||||
Diluted | $ | (0.21) | $ | (0.20) | ||||
Weighted average shares of Common Stock outstanding: | ||||||||
Basic and diluted | 16,992 | 15,702 |
Adjusted EBITDA
We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation expense, merger and acquisition costs, restructuring, transition and acquisitions expense, net, goodwill impairment and certain other items.
Adjusted EBITDA is not a measurement of financial performance under GAAP and may not be comparable to other similarly titled measures of other companies. We use Adjusted EBITDA as a financial metric to measure the financial performance of the business, because management believes it provides additional information with respect to the performance of its fundamental business activities. For this reason, we believe Adjusted EBITDA will also be useful to others, including our stockholders, as a valuable financial metric.
We present Adjusted EBITDA because we believe that Adjusted EBITDA is a useful supplement to net income (loss) from continuing operations as an indicator of operating performance. We also believe that Adjusted EBITDA is a financial measure that is useful both to management and investors when evaluating our performance and comparing our performance with that of our competitors. We also use Adjusted EBITDA for planning purposes, and to evaluate our financial performance because Adjusted EBITDA excludes certain incremental expenses or non-cash items, such as stock-based compensation charges, that we believe are not indicative of our ongoing operating performance.
We believe that Adjusted EBITDA is a performance measure and not a liquidity measure, and therefore a reconciliation between net income (loss) from operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to net income (loss) from operations as an indicator of performance, or as an alternative to cash flows from operating activities as an indicator of cash flows, in each case as determined in accordance with GAAP, or as a measure of liquidity. In addition, Adjusted EBITDA does not take into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.
Following is the reconciliation of our consolidated net income (loss) to Adjusted EBITDA (in thousands) :
For the Three Months Ended | ||||||||
2025 | 2024 | |||||||
Net Loss | $ | (3,516) | $ | (3,050) | ||||
Add Backs: | ||||||||
Income tax expense | 14 | 7 | ||||||
Depreciation and amortization | 1,147 | 948 | ||||||
Interest (income) expense | (278) | 431 | ||||||
Stock-based compensation | 418 | 470 | ||||||
Other expense (income), net | 78 | (166) | ||||||
Net income attributable to noncontrolling interest | (44) | (23) | ||||||
Transition-related costs | 47 | 27 | ||||||
Adjusted EBITDA | $ | (2,134) | $ | (1,357) |
SOURCE Cineverse Corp.
14 augusti, 22:01
Cineverse Reports First Quarter Fiscal Year 2026 Results
PR Newswire
LOS ANGELES, Aug. 14, 2025
Total Revenue of $11.1 Million , a $2.0 million or 22% Increase over Prior Year Quarter
Direct Operating Margin of 57%, a 6% Improvement over Prior Year Quarter
LOS ANGELES , Aug. 14, 2025 /PRNewswire/ -- Cineverse Corp. ("Cineverse" or the "Company") (NASDAQ: CNVS), a global streaming technology and entertainment company, today announced its financial results for its first quarter ended June 30, 2025 ("Q1 FY 2026"):
The Company's Total Revenue and Direct Operating Margin improved significantly over the prior year quarter while Net Loss and Adjusted EBITDA decreased slightly due to increased SG&A costs directly attributable to the investments required to support our increased theatrical slate and build out of an enhanced business development, product and sales team for our Technology group.
Following the unprecedented success of Terrifier 3 , the most successful unrated film release of all time, we continue to build a slate of additional wide release films that we believe can provide a strong and ongoing source of profits for the Company. The Toxic Avenger Unrated , produced by major studio Legendary Films (Dune, Godzilla x Kong, etc.), hits theatres on August 29 , 2025. After that, Silent Night, Deadly Night , a re-interpretation of the classic controversial horror film, is scheduled for release on December 12, 2025 . Next will be Return to Silent Hill , the latest film installment of the enormously successful video game franchise, on January 23 , 2026. Additionally, in summer 2026, we will release Air Bud Returns , the latest installment of the beloved family film franchise. We will also be releasing Wolf Creek : Legacy , the third installment of the classic Australian Outback horror/thriller film, in 2027. Based on the results of Terrifier 2 and Terrifier 3 , other major studios also continue to utilize our new media ecosystem to market their releases, emphasizing the impact our unique and innovative marketing approach has had on the industry.
The Company continues to be in a strong financial position as of June 30, 2025 with almost $10.9 million in cash-on-hand and availability on our current $12.5 million line of credit facility with East West Bank .
Q1 FY 2026 Highlights (all comparisons are to the prior year fiscal quarter ended June 30, 2024 , or Q1 FY 2025):
Total quarterly revenue was $11.1 million versus $9.1 million in the prior-year period, a 22% increase, driven by gains in streaming and digital distribution, as well as theatrical and physical sales.
SG&A expenses increased by $2.4 million , or 36%, to $9.0 million , reflecting increased compensation, marketing and legal costs as a result of ramping up for an increased theatrical slate for the remainder of the year. The Company's SG&A costs are typically higher in the first quarter of the fiscal year due to increased costs associated with year-end audit, tax and Sarbanes-Oxley compliance.
Net loss attributable to common stockholders was $3.6 million , or $(0.21) per basic and diluted share, compared to a net loss of $3.2 million , or $(0.20) per share, in the prior-year quarter. Adjusted EBITDA was $(2.1) million , compared to $(1.4) million last year.
Financial Condition Overview:
Operational Developments During the Quarter:
Operational Developments Subsequent to Quarter-End:
Management Commentary:
Chris McGurk , Cineverse Chairman and CEO , stated: "We had another strong quarter from a Revenue standpoint, with significant growth across all of our lines of business. Our total Operating Margin also increased significantly. Investments in SG&A and marketing to support our expanding theatrical business and our Technology Group impacted our Adjusted EBITDA and Net Income. However, we expect to begin to see returns from those investments beginning in our fiscal second quarter."
"The Toxic Avenger Unrated hits theaters on August 29 , and received a strong response at Comic-Con last month. Similar to Terrifier 3 , our total investment in this film, including release marketing, is less than $5 million . However, since we bought out all domestic rights in all media for the film in perpetuity under a unique deal structure, the risk/reward profile for this film is much more favorable for Cineverse."
"We also added another high potential film to our slate: We will be releasing Air Bud Returns , the latest theatrical installment of the beloved film and TV family franchise that was previously distributed for more than the last two decades by the Walt Disney Company, next summer. Our announcement of Air Bud Returns garnered huge interest across all media including features on Good Morning America and The Today Show."
"Finally, we recently announced a 50/50 joint venture for MicroCo, a new studio and platform for Microseries, a market projected to reach $10 billion by 2027. Our partner for MicroCo is Lloyd Braun's Banyan Ventures. Lloyd is the former Chairman of ABC Entertainment and WME. Joining the venture as CEO will be Jana Winograde , former Showtime President, and CCO Susan Rovner, former Chairman of NBC/Universal Television and Streaming. We believe Cineverse's unique set of streaming, content, technology and AI capabilities will provide a tremendous foundation of assets for this elite leadership team to rapidly build an industry-leading business in this high growth sector."
Erick Opeka , Cineverse President and Chief Strategy Officer , stated: "Cineverse is proving that when you combine owned ad tech, proprietary media networks, and a disciplined theatrical acquisition strategy, you can achieve studio-level awareness with a fraction of the spend. Ahead of its release, awareness tracking for The Toxic Avenger Unrated is already above its opening weekend peers across multiple third-party measurement sources while our marketing investment remains less than ten percent of comparable studio campaigns. This is the advantage of controlling the pipes and the platform."
"The same machine driving that theatrical awareness is also fueling growth across our streaming business, with total minutes streamed up 38% year-over-year to more than 4.0 billion and FAST viewing up 20%. Screambox viewership has climbed 26% since the release of Terrifier 3 , showing how our approach can both launch films and deepen engagement across our platforms. The addition of industry leader Michele Edelman to head sales and marketing for Matchpoint strengthens our ability to extend these results to new enterprise clients."
"Our recently announced MicroCo joint venture is another example of how we intend to lead emerging formats rather than follow them. Our goal is to build the infrastructure layer for the entire microdrama space, unifying content, creators, fandom, and monetization under one platform. Powered by Cineverse's proprietary technology and AI capabilities, MicroCo will support all forms of content generation, from premium live-action to AI-assisted production, hybrid workflows, animation, and creator-led formats. Backed by some of the most accomplished executives in the history of television and combined with our distribution, marketing, and data-driven audience development tools, we believe MicroCo can define the future of short-form storytelling and become the standard the category grows on."
Conference Call
Cineverse will host a conference call at 4:30 p.m. EST / 1:30 p.m. PST ( Thursday, August 14, 2025 ), during which management will discuss the results of its fiscal first quarter ended June 30, 2025 .
Call details are as follows:
About Cineverse
Cineverse (Nasdaq: CNVS) is a next-generation entertainment studio that empowers creators and entertains fans with a wide breadth of content through the power of technology. It has developed a new blueprint for delivering entertainment experiences to passionate audiences and results for its partners with unprecedented efficiency, and distributes more than 71,000 premium films, series, and podcasts. Cineverse connects fans with bold, authentic, independent stories. Properties include the highest-grossing unrated film in U.S. history ; dozens of streaming fandom channels; a premier podcast network; top horror destination Bloody Disgusting; and more. Powering visionary storytelling with cutting-edge innovation, Cineverse's proprietary streaming tools and AI technology drive revenue and reach to redefine the next era of entertainment. For more information, visit home.cineverse.com .
Safe Harbor Statement
Investors and readers are cautioned that certain statements contained in this document, as well as some statements in periodic press releases and some oral statements of Cineverse officials during presentations about Cineverse, along with Cineverse's filings with the Securities and Exchange Commission, including Cineverse's registration statements, quarterly reports on Form 10-Q and annual report on Form 10-K, are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act''). Forward-looking statements include statements that are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "expects," "anticipates,'' "intends,'' "plans,'' "could," "might," "believes,'' "seeks," "estimates'' or similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings, or growth rates), ongoing business strategies or prospects, and possible future actions, which may be provided by Cineverse's management, are also forward-looking statements as defined by the Act. Forward-looking statements are based on current expectations and projections about future events and are subject to various risks, uncertainties, and assumptions about Cineverse, its technology, economic and market factors, and the industries in which Cineverse does business, among other things. These statements are not guarantees of future performance, and Cineverse undertakes no specific obligation or intention to update these statements after the date of this release.
For additional information, please contact:
Julie Milstead
424-281-5411
investorrelations@cineverse.com
CINEVERSE CORP. | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(in thousands) | ||||||||
As of | ||||||||
June 30, | March 31, | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | 1,985 | $ | 13,941 | ||||
Accounts receivable, net | 16,073 | 15,752 | ||||||
Content advances | 5,168 | 6,736 | ||||||
Other current assets | 1,637 | 1,652 | ||||||
Total Current Assets | 24,863 | 38,081 | ||||||
Property and equipment, net | 2,968 | 2,876 | ||||||
Intangible assets, net | 18,449 | 18,168 | ||||||
Goodwill | 6,799 | 6,799 | ||||||
Content advances, net of current portion | 5,853 | 4,053 | ||||||
Other long-term assets | 2,602 | 2,539 | ||||||
Total Assets | $ | 61,534 | $ | 72,516 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities | ||||||||
Accounts payable and accrued expenses | $ | 20,757 | $ | 31,109 | ||||
Line of credit | 3,628 | - | ||||||
Current portion of earnout and deferred consideration on purchase of business | 464 | 2,956 | ||||||
Current portion of operating lease liabilities | 191 | 187 | ||||||
Current portion of deferred revenue | 99 | 183 | ||||||
Total Current Liabilities | 25,139 | 34,435 | ||||||
Operating lease liabilities, net of current portion | 226 | 275 | ||||||
Other long-term liabilities | 15 | 14 | ||||||
Total Liabilities | 25,380 | 34,724 | ||||||
Stockholders' Equity | ||||||||
Preferred stock | 3,559 | 3,559 | ||||||
Common Stock | 195 | 194 | ||||||
Additional paid-in capital | 551,320 | 548,405 | ||||||
Treasury stock, at cost | (13,158) | (12,193) | ||||||
Accumulated deficit | (504,557) | (500,908) | ||||||
Accumulated other comprehensive loss | (289) | (305) | ||||||
Total stockholders' equity of Cineverse Corp. | 37,070 | 38,752 | ||||||
Deficit attributable to noncontrolling interest | (916) | (960) | ||||||
Total equity | 36,154 | 37,792 | ||||||
Total Liabilities and Equity | $ | 61,534 | $ | 72,516 |
CINEVERSE CORP. | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||
(In thousands, except for per share data) | ||||||||
(Unaudited) | ||||||||
Three Months Ended | ||||||||
2025 | 2024 | |||||||
Revenues | $ | 11,119 | $ | 9,127 | ||||
Operating expenses | ||||||||
Direct operating | 4,807 | 4,479 | ||||||
Selling, general and administrative | 8,952 | 6,563 | ||||||
Depreciation and amortization | 1,062 | 863 | ||||||
Total operating expenses | 14,821 | 11,905 | ||||||
Operating loss | (3,702) | (2,778) | ||||||
Interest income (expense) | 278 | (431) | ||||||
Other (expense) income, net | (78) | 166 | ||||||
Net loss before income taxes | (3,502) | (3,043) | ||||||
Income tax expense | (14) | (7) | ||||||
Net loss | (3,516) | (3,050) | ||||||
Net income attributable to noncontrolling interest | (44) | (23) | ||||||
Net loss attributable to controlling interests | (3,560) | (3,073) | ||||||
Preferred stock dividends | (89) | (89) | ||||||
Net loss attributable to common stock holders | $ | (3,649) | $ | (3,162) | ||||
Net loss per share attributable to common stockholders: | ||||||||
Basic | $ | (0.21) | $ | (0.20) | ||||
Diluted | $ | (0.21) | $ | (0.20) | ||||
Weighted average shares of Common Stock outstanding: | ||||||||
Basic and diluted | 16,992 | 15,702 |
Adjusted EBITDA
We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation expense, merger and acquisition costs, restructuring, transition and acquisitions expense, net, goodwill impairment and certain other items.
Adjusted EBITDA is not a measurement of financial performance under GAAP and may not be comparable to other similarly titled measures of other companies. We use Adjusted EBITDA as a financial metric to measure the financial performance of the business, because management believes it provides additional information with respect to the performance of its fundamental business activities. For this reason, we believe Adjusted EBITDA will also be useful to others, including our stockholders, as a valuable financial metric.
We present Adjusted EBITDA because we believe that Adjusted EBITDA is a useful supplement to net income (loss) from continuing operations as an indicator of operating performance. We also believe that Adjusted EBITDA is a financial measure that is useful both to management and investors when evaluating our performance and comparing our performance with that of our competitors. We also use Adjusted EBITDA for planning purposes, and to evaluate our financial performance because Adjusted EBITDA excludes certain incremental expenses or non-cash items, such as stock-based compensation charges, that we believe are not indicative of our ongoing operating performance.
We believe that Adjusted EBITDA is a performance measure and not a liquidity measure, and therefore a reconciliation between net income (loss) from operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to net income (loss) from operations as an indicator of performance, or as an alternative to cash flows from operating activities as an indicator of cash flows, in each case as determined in accordance with GAAP, or as a measure of liquidity. In addition, Adjusted EBITDA does not take into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.
Following is the reconciliation of our consolidated net income (loss) to Adjusted EBITDA (in thousands) :
For the Three Months Ended | ||||||||
2025 | 2024 | |||||||
Net Loss | $ | (3,516) | $ | (3,050) | ||||
Add Backs: | ||||||||
Income tax expense | 14 | 7 | ||||||
Depreciation and amortization | 1,147 | 948 | ||||||
Interest (income) expense | (278) | 431 | ||||||
Stock-based compensation | 418 | 470 | ||||||
Other expense (income), net | 78 | (166) | ||||||
Net income attributable to noncontrolling interest | (44) | (23) | ||||||
Transition-related costs | 47 | 27 | ||||||
Adjusted EBITDA | $ | (2,134) | $ | (1,357) |
SOURCE Cineverse Corp.
Aktieanalyser
Börsen
New Wave
Rapporter
Aktieanalyser
Börsen
New Wave
Rapporter
1 DAG %
Senast
Boozt
15 augusti, 17:40
Saab gick mot strömmen inför toppmöte – OMXS30 +0,3%
Bure Equity
15 augusti, 16:14
Tufft kvartal för Bure: "Aktiemarknaden är hänsynslös"
Riksbanken
15 augusti, 16:02
Profilen om ekonomin: "Som en snigel i uppförsbacke"
kronan
15 augusti, 15:44
Nordea om svenska kronan: Som blommorna vid jordfästningen
OMX Stockholm 30
1 DAG %
Senast
2 640,70